3-Iodo-4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)benzamide

Catalog No. :
ACOAUF101
CAS No. :
926922-18-1
Molecular Formula :
C19H15F3IN3O
Molecular Weight :
485.25

IUPAC Name:3-iodo-4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)benzamide

3-Iodo-4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)benzamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Iodo-4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)benzamide
IUPAC Name3-iodo-4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)benzamide
Molecular FormulaC19H15F3IN3O
Molecular Weight485.25
SMILESO=C(NC1=CC(N2C=C(C)N=C2)=CC(C(F)(F)F)=C1)C3=CC=C(C)C(I)=C3
InChI KeyWDDHGZLDAZNYLH-UHFFFAOYSA-N
Synonym3-iodo-4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]benzamide;3-Iodo-4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]benzamide;N-(3-(Trifluoromethyl)-5-(4-methyl-1H-imidazol-1-yl)phenyl)-3-iodo-4-methylbenzamide;Nilotinib Iodo Impurity;Benzamide, 3-iodo-4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-
CAS No.926922-18-1

Synthetic Route by SureRoute

1. ACOAUF101 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQGOH581 route compound structure diagram
    ACQGOH58182998-57-0 In Stock
  2. Plus
  3. ACRCKO903 route compound structure diagram
    ACRCKO903641571-11-1 In Stock
  4. Then
  5. ACOAUF101 route product structure diagram
    ACOAUF101926922-18-1
Inquiry

2. ACOAUF101 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRCKO903 route compound structure diagram
    ACRCKO903641571-11-1 In Stock
  2. Then
  3. ACOAUF101 route product structure diagram
    ACOAUF101926922-18-1
Inquiry

Comments (0)